TRES BIOTECHNOLOGY AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−6k kr).

TRES BIOTECHNOLOGY AS is registered as a limited company in Bergen, Vestland with organisation number 932418207. The business is classified under all other professional, scientific and technical activities n.e.c. (NACE 74.990). The company was incorporated in 2023. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Rådgivning og tjenester i bioteknologi. Holdingselskap for selskaper innen livsvitenskaper.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −6,000 in operating profit.

Key figures · 2025

Revenue

NOK 0

Operating profit

NOK −6,000

Equity

NOK 148,000

Est. value

NOK 240,000

Financial health · 2025

Liquidity

6.59

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

85.5%

Very good

Equity as a share of total capital

Who owns TRES BIOTECHNOLOGY AS?

BJØRN TORE GJERTSEN

50.0%

TRES BIOTECHNOLOGY AS

NOK 0 rev. · NOK −6,000 profit

TRES BIOTECHNOLOGY AS has 2 registered shareholders:

• BJØRN TORE GJERTSEN 50.0%
• LIV TURID BERTELSEN 50.0%

All shareholders and roles →

Which companies does TRES BIOTECHNOLOGY AS own?

TRES BIOTECHNOLOGY AS holds stakes in 2 companies:

• HÁ BIOTECH AS 40.0%
• BJØRGVIN THERAPEUTICS GROUP AS 14.5%

See the full ownership structure →

Frequently asked questions about TRES BIOTECHNOLOGY AS

Who owns TRES BIOTECHNOLOGY AS?

BJØRN TORE GJERTSEN is the largest registered owner, with 50.0%.

What is the revenue of TRES BIOTECHNOLOGY AS?

TRES BIOTECHNOLOGY AS had revenue of NOK 0 in 2025.

Where is TRES BIOTECHNOLOGY AS based?

TRES BIOTECHNOLOGY AS has its business address in Morvik.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.